To Top Skip to content

Tag Archives: children’s migraines

Menstrual Migraines in Adolescents

Many adult women who suffer from chronic migraine headaches find that many, if not most of their headaches occur between 2 days before menstruation and 2-3 days after menstruation. These migraines are referred to as “menstrual” or hormonally related migraines.

Recently researchers at Cincinnati’s Children’s Hospital completed a study analyzing what percentage of adolescent, menstruating young women experienced “menstrual” or “hormonally” related migraines.

It was found that out of the 891 adolescent girls studied, 50% experienced a headache during their first period upon entering puberty and almost 40% of these adolescents continued to experience migraines just before or just after their periods.

These migraines are brought about by both the hormonal shifts that occur during menstruation as well as changes in blood sugar levels. They are often accompanied by PMS symptoms of bloating, breast pain, irritability, cravings, acne, poor sleep and anxiety, as well.

Correcting these imbalances can reduce or eliminate both migraines and many of the symptoms of PMS.

Our own clinical observations indicate that addressing hormonal shifts without also balancing blood sugar levels leads to less comprehensive benefits not only regarding migraine prophylaxis but regarding the afore mentioned symptoms associated with PCOS. Therefore we recommend adding to any proposed regimen, ingredients like chromium picolinate, or other insulin sensitizing ingredients, plus additional dietary fiber to prevent spiking of blood glucose levels that can often lead to the precipitous drops associated with hypoglycemia.

We at MigreLief have created a safe, gentle and natural medicine for adolescent and adult women suffering from both/either menstrual/hormonally related migraines and monthly symptoms of PMS, it is called MigreLief+M. It will be available in 1-2 months. We will announce it’s availability on our Twitter, Face book and MigreLief blog sites.

>To your good health,

Curt Hendrix M.S. C.C.N. C.N.S.
Chief Science Officer, Akeso Health Sciences L.L.C.

HEADACHES/MIGRAINES IMPAIR ATTENTION IN CHILDREN AND ADOLESCENTS AND MAY NEGATIVELY IMPACT LEARNING

It is difficult enough for children to perform academically at acceptable levels in school. The last thing they need is the pain of headaches and migraines to decrease their ability to pay attention and learn.

However this is exactly what happens to them according to a study done in Milan, Italy and published in the journal “Headache”.

The researchers compared 14 children who had migraines with aura, 29 who had migraines without aura and 19 with tension type headaches versus 52 children without headache that were matched for age, sex and intelligence.

Upon analyzing the data the researchers found that regardless of the type of headache they had, the children in the headache group had problems paying attention when compared to the non-headache children. The researchers stated that this could lead to long term negative impact on learning and academic performance.

Loading these children up with pain fighting medications, many of which have undesirable side-effects, is not the answer to helping these children. Preventing the migraines from occurring at all or significantly reducing the number and intensity of migraines, is clearly the first choice for parents who are trying to figure out what to do.

The natural, safe and mild option of original MigreLief, for children 12 and above and Children’s MigreLief for children ages 2-11 is the answer. For more information, please go to www.MigreLief.com
Curt Hendrix, M.S., C.C.N., C.N.S.

 

At Last! Nutritional Support For Children’s Migraines – The First Natural Migraine Supplement Just for Kids

At Last! Nutritional Support for Children’s Migraines!
The First Natural Migraine Supplement Just for Kids – Children’s MigreLief

 

LOS ANGELES, Dec. 23, 2010 /PRNewswire/ — MigreLief, the first name in migraine support, releases a safe and proven effective supplement for children of all ages:

 

One of the hardest things for a parent to do is to see their child in pain.  Yet every day millions of parents must watch helplessly as their children suffer from debilitating attacks.  About one out of every ten kids, or nearly 8 million children in the United States alone, are plagued by what has become the most common acute and recurrent headache pattern experienced by children today.

“Be it supplement, OTC drug or prescription drug, Children’s MigreLief is the first and only therapy developed specifically for children suffering from migraine headaches,” explains Curt Hendrix M.S. C.C.N, C.N.S., scientist and creator of Children’s MigreLief.  These often incapacitating experiences strike suddenly and often with accompanying symptoms of nausea, abdominal pain and vomiting. Until now, the only option available was the use of side-effect prone prescription medications actually causing more migraines, known as rebound headaches. But Children’s MigreLief offers parents of children suffering migraines a safe nutritional option, with none of the potentially disruptive side-effects of prescription drugs.

Hendrix explains, “There is NOT one prescription drug approved by the FDA for use by children with migraines. The side-effects of these drugs are significant in adults and not an option most parents would want to subject a child to. Children’s MigreLief is the perfect solution… a vitamin, a mineral and a plant, all well known for their safety, efficacy and low side-effects to establish normal vascular function instead of a lifetime on pain killers and abortive drugs.”

MigreLief contains a patented “Triple Therapy” approach to reestablishing normal cerebrovascular tone and function that is disrupted in children who have migraines.  Nutritional deficiencies, inflammation, and vasospasm can independently and together contribute to migraine occurrence, frequency and intensity.  Children’s MigreLief contains the same “Triple Therapy” ingredients as MigreLief but with dosages and pill sizes adjusted to meet the needs of children.

MigreLief’s ingredients; Puracol, a proprietary blend of two unique Feverfew sources, Magnesium from two sources and high dose, highly absorbable Riboflavin (Vitamin B-2) have all independently been shown to be of significant benefit to migraine sufferers.

All MigreLief products are available in select pharmacies and online at MigreLief.com. For more information and product samples contact sales@akesohealth.com.

About Akeso Health Sciences

Founded by Curt Hendrix in 1992, the company now Akeso L.L.C. is a family company dedicated to continuing research and breakthrough technologies for the development of patented supplements. Akeso has helped tens of thousands control their migraines to find new joy and peace in life and consistently delivers innovative, leading edge solutions for migraineurs worldwide.

Contact: Steve Hendrix sales@akesohealth.com USA (800) 758-8746

DISCLAIMER: (MigreLief™) is not intended to diagnose, treat, cure, or prevent any disease or illness.  Please consult your licensed medical practitioner if you have, or suspect you may have, a health problem.

SOURCE Akeso Health Sciences and PRNewswire.com

 

RELATED PRODUCTS

 

Migrelief+MCHILDREN’S MIGRELIEF

For children under the age of 12 who suffer from migraine headaches.

» Buy Now

 

 

Riboflavin Prophylaxis in Pediatric and Adolescent Migraine – Journal of Headache Pain Reports…

J Headache Pain. 2009 Oct;10(5):361-5. Epub 2009 Aug 1.

Riboflavin prophylaxis in pediatric and adolescent migraine.

Condò M, Posar A, Arbizzani A, Parmeggiani A.

Department of Neurological Sciences, University of Bologna, Bologna, Italy.

Abstract

Migraine is a common disorder in childhood and adolescence. Studies on adults show the effectiveness and tolerability of riboflavin in migraine prevention, while data on children are scarce. This retrospective study reports on our experience of using riboflavin for migraine prophylaxis in 41 pediatric and adolescent patients, who received 200 or 400 mg/day single oral dose of riboflavin for 3, 4 or 6 months. Attack frequency and intensity decreased (P < 0.01) during treatment, and these results were confirmed during the follow-up. A large number of patients (77.1%) reported that abortive drugs were effective for controlling ictal events. During the follow-up, 68.4% of cases had a 50% or greater reduction in frequency of attacks and 21.0% in intensity. Two patients had vomiting and increased appetite, respectively, most likely for causes unrelated to the use of riboflavin. In conclusion, riboflavin seems to be a well-tolerated, effective, and low-cost prophylactic treatment in children and adolescents suffering from migraine.

PMID: 19649688 [PubMed – indexed for MEDLINE]